TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
QUIA PHARMA AB (publ)
Closing information (x1000 NOK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
0
|
0
|
211 |
| Financial expenses |
1,026
|
4,063
|
2,371 |
| Earnings before taxes |
-16,738
|
-19,002
|
-19,504 |
| EBITDA |
-11,805
|
-11,754
|
-14,986 |
| Total assets |
42,506
|
22,174
|
23,175 |
| Current assets |
1,787
|
3,559
|
6,135 |
| Current liabilities |
27,056
|
5,508
|
6,553 |
| Equity capital |
15,450
|
2,282
|
22 |
| - share capital |
23,611
|
22,412
|
41,615 |
| Employees (average) |
3
|
4
|
5 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
36.3%
|
10.3%
|
0.1% |
| Turnover per employee |
0
|
0
|
42 |
| Profit as a percentage of turnover | -9243.6% | ||
| Return on assets (ROA) |
-37.0%
|
-67.4%
|
-73.9% |
| Current ratio |
6.6%
|
64.6%
|
93.6% |
| Return on equity (ROE) |
-108.3%
|
-832.7%
|
-88654.5% |
| Change turnover |
0
|
-204
|
-1,604 |
| Change turnover % |
-100%
|
-88% | |
| Chg. No. of employees |
-1
|
-1
|
2 |
| Chg. No. of employees % |
-25%
|
-20%
|
67% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.